American Vanguard (NYSE:AVD) Stock Rating Lowered by Wall Street Zen

Key Points

• Wall Street Zen downgraded American Vanguard from “hold” to “sell,” while Weiss Ratings also lowered its rating; MarketBeat data shows an average “Sell” rating.
• American Vanguard’s shares opened at $2.10, near their 52-week low of $2.05, with a market capitalization of approximately $62.1 million. The stock’s 50-day and 200-day moving averages were $2.63 and $3.20, respectively.
• The company reported a quarterly loss of $0.34 per share, missing the $0.09 consensus estimate, while revenue of $116.75 million fell short of expectations of $135 million. A director purchased 25,000 shares, and institutional investors own approximately 79% of the stock.

American Vanguard (NYSE:AVD - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday.

Separately, Weiss Ratings cut American Vanguard from a "sell (d-)" rating to a "sell (e+)" rating in a research note on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has an average rating of "Sell".

American Vanguard Price Performance

Shares of NYSE AVD opened at $2.10 on Friday. American Vanguard has a 1 year low of $2.05 and a 1 year high of $5.92. The company has a debt-to-equity ratio of 1.46, a current ratio of 2.47 and a quick ratio of 1.41. The company's 50-day moving average is $2.63 and its 200 day moving average is $3.20. The stock has a market capitalization of $62.10 million, a P/E ratio of -1.11 and a beta of 1.43.

American Vanguard (NYSE:AVD - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The basic materials company reported ($0.34) EPS for the quarter, missing the consensus estimate of $0.09 by ($0.43). The company had revenue of $116.75 million during the quarter, compared to analysts' expectations of $135.00 million. American Vanguard had a negative return on equity of 9.05% and a negative net margin of 10.70%.

Insider Activity

In other American Vanguard news, Director Patrick E. Gottschalk purchased 25,000 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was bought at an average cost of $2.70 per share, with a total value of $67,500.00. Following the transaction, the director directly owned 191,705 shares in the company, valued at approximately $517,603.50. The trade was a 15.00% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 5.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On American Vanguard

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. R Squared Ltd bought a new position in shares of American Vanguard during the first quarter valued at approximately $28,000. Strs Ohio bought a new stake in shares of American Vanguard in the 1st quarter worth approximately $28,000. nVerses Capital LLC purchased a new stake in shares of American Vanguard in the 4th quarter worth approximately $42,000. Virtu Financial LLC purchased a new stake in shares of American Vanguard in the 4th quarter worth approximately $52,000. Finally, Jain Global LLC bought a new position in American Vanguard during the 4th quarter valued at approximately $53,000. Hedge funds and other institutional investors own 79.00% of the company's stock.

About American Vanguard

American Vanguard Corporation NYSE: AVD is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company's product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source